Compare MRKR & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRKR | MSGM |
|---|---|---|
| Founded | 1999 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 19.0M |
| IPO Year | 2010 | 2020 |
| Metric | MRKR | MSGM |
|---|---|---|
| Price | $1.13 | $4.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 58.6K | 22.4K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.61 | ★ 252.13 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $741,000.00 |
| Revenue This Year | N/A | $69.73 |
| Revenue Next Year | $936.27 | $146.81 |
| P/E Ratio | ★ N/A | $75.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $2.11 |
| 52 Week High | $2.46 | $5.78 |
| Indicator | MRKR | MSGM |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 54.39 |
| Support Level | $0.96 | $3.71 |
| Resistance Level | $1.52 | $4.93 |
| Average True Range (ATR) | 0.07 | 0.31 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 27.91 | 57.14 |
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
Motorsport Games Inc is a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, including games based on the 24 Hours of Le Mans endurance race (Le Mans) and the associated FIA World Endurance Championship (the WEC). Its portfolio also includes the KartKraft karting simulation game, as well as Studio 397 B.V. (Studio397) and their rFactor 2 realistic racing simulator technology and platform. The games are developed and published for personal computers (PCs) through various digital channels, including full-game and downloadable content (DLC). Additionally, Motorsport Games organizes esports tournaments, competitions, and events. Its reportable segments are: Gaming, which generates the maximum revenue, and Esports.